Rectify Pharma
PrivateLast Round
Strategic
Dec 22, 2025
Total Funding Raised
$100M
Company Overview
Rectify Pharma is a biotechnology company developing disease-modifying precision therapies through positive functional modulators that restore ABC transporter function to treat genetic disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rectify Pharma Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Rectify Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 22, 2025 | ||||
| Series A | Oct 14, 2021 |
Key People
Founding team and executive leadership
Rectify Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Boehringer Ingelheim | Strategic |
| Omega Funds | Series A |
| Dean Capital Investments Management | Series A |
| Forbion | Series A |
| Atlas Venture | Series A |
| Longwood Fund | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 22, 2025
Partnered with Boehringer Ingelheim to develop treatments for chronic kidney disease.
- May 9, 2025
Presented hepatobiliary program data at the EASL 2025 Congress.
Rectify Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rectify Pharma's valuation, stock price, and market status.